Granulosa cells proliferate and then undergo differentiation; an inverse relationship between these processes is observed during terminal follicular growth. During terminal follicular growth and initial luteinization, there is a necessary transition of granulosa cells to a less proliferative and highly steroidogenic form in response to LH. Although the expression of several molecules has been reported to be up-regulated by LH, proliferation/differentiation transition is not fully understood. Here, we show that the expression of a tumor suppressor, phosphatase and tensin homologue deleted on chromosome 10 (PTEN) was induced with human chorionic gonadotropin (hCG) treatment in human luteinized granulosa cells. Pretreatment with hCG attenuated insulin-like growth factor (IGF)-1-induced phosphorylation of AKT and cell proliferation, not phosphorylation of ERK1/2. Moreover, suppression of hCG-induced PTEN expression with siRNA increased AKT phosphorylation and cell proliferation in response to IGF1. We also demonstrate that a PI3K inhibitor, LY294002, not a MEK inhibitor, PD98059, inhibited IGF1-induced cell proliferation. In conclusion, PTEN induced to express by hCG in luteinized granulosa cells that inactivates AKT, not ERK, and attenuates IGF1-induced cell proliferation. PTEN expression may be a trigger for proliferation/differentiation transition in human granulosa cells. 
Introduction
The maturation of oocytes is under the regulatory control of signals from proliferating granulosa cells, in response to stimulation by gonadotropin and growth factors (Moor et al. 1998) . Although, FSH plays the most significant role in the folliculogenesis in post-secondary stages of follicle development, several studies have shown the involvement of insulin-like growth factor (IGF)-1 in the survival of granulosa cells in humans (Poretsky et al. 1999 , Bencomo et al. 2006 ) and other species (Guthrie et al. 1998 , Johnson et al. 2001 ) to be comparable with that of FSH. The biological functions of IGF1 are mainly mediated by the type-I IGF receptor (IGF1R), which is able to activate the phosphatidylinositol 3-kinase (PI3K)/AKT pathway (Roberts 1996) . PI3K generates phosphatidylinositol-3,4,5-triphosphate (PIP3), which activates multiple downstream effectors including AKT, by phosphorylating phosphatidylinositol-4,5-biphosphate (PIP2; Cantley & Neel 1999) . Such activation is correlated with cell survival in a wide variety of cells, including those of epithelial, mesenchymal, and neuronal origin (Datta et al. 1997 , Kulik et al. 1997 , as well as cancer cells (Sumitomo et al. 2004) . In bovine granulosa cells, AKT, a downstream substrate of PI3K, was necessary for the protective effect of IGF1 against FASL-induced apoptosis . AKT has also been demonstrated to be involved in granulosa cell survival in hens (Johnson et al. 2001) and pigs (Westfall et al. 2000) .
During terminal follicular growth and initial luteinization, granulosa cells change to a less proliferative and highly steroidogenic form in response to LH, which is the trigger of ovulation and luteinization. The expression of a wide spectrum of genes has been demonstrated to be modulated by LH , which may affect changes induced by FSH and/or IGF1 and cause maturation of granulosa cells. However, the mechanism of this LH-responsive differentiation/maturation has not been entirely revealed.
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) lipid phosphatase antagonizes the activity of PI3K by dephosphorylating PIP3 to PIP2 (Maehama & Dixon 1998) . Therefore, PTEN indirectly inhibits the phosphorylation of AKT and its activation or inactivation results in decreased or increased AKT activity (Leslie & Downes 2004) . Originally, PTEN was reported to be a tumor suppressor frequently inactivated in a number of cancers including prostate, brain, and endometrial cancer. Recently, alterations in the expression and activity of PTEN have been proposed to play a causal role in the development of several conditions other than cancer, including rheumatoid arthritis, chronic obstructive pulmonary disease, and pulmonary fibrosis (Anderson & Bozinovski 2003 , White et al. 2003 . Theoretically, the balance between PI3K and PTEN determines PIP3 levels, which affect a variety of intracellular signals, such as AKT. Recently, we have reported that PTEN expression becomes intense during follicular growth, whereas the intensity of phospho-AKT becomes weak in granulosa cells, which suggests PTEN to be involved in the regulation of proliferation and differentiation of granulosa cells in human ovary via modulation of the PI3K/AKT pathway (Goto et al. 2007) .
Therefore, the aim of the present study was to test the hypothesis that PTEN expression is induced during luteinization and affects granulosa cell proliferation via dephosphorylation of AKT. We also investigated the contrast in signaling pathways between AKT and ERK.
Results

Induction of PTEN expression with human chorionic gonadotropin in primary cultured luteinized granulosa cells
We first performed western blotting and real-time RT-PCR using primary cultured luteinized granulosa cells to assess the expression and induction of PTEN with human chorionic gonadotropin (hCG) stimulation. Western blotting showed that luteinized granulosa cells expressed PTEN, which was up-regulated with hCG in a dose-dependent manner (Fig. 1A) and in a time course up to 48 h (Fig. 1B) . Real-time RT-PCR showed an w1.7-fold increase in the level of PTEN mRNA with 1 or 10 IU/ml hCG (Fig. 1C) .
Inhibition of IGF1-induced AKT phosphorylation, but not ERK phosphorylation, by hCG pretreatment
We next explored the signaling pathways downstream of IGF1 in luteinized granulosa cells with or without hCG pretreatment. IGF1 induced phosphorylation of AKT and ERK1/2 without hCG pretreatment. ERK1/2 was slightly phosphorylated with hCG treatment, while AKT was not phosphorylated with hCG. Pretreatment with hCG induced expression of PTEN and inhibited IGF1-induced phosphorylation of AKT, but not ERK1/2. Expression of IGF1R was not affected by hCG (Fig. 2) .
Inhibition of IGF1-induced cell proliferation
Recent studies demonstrated that IGF1 stimulates proliferation of granulosa cells via the PI3K/AKT pathway (Westfall et al. 2000 . Therefore, we examined whether IGF1 stimulates proliferation of human luteinized granulosa cells and whether hCG affects IGF1-induced cell proliferation. A bromodeoxyuridine (BrdU) cell proliferation assay revealed that IGF1 induced DNA synthesis in luteinized granulosa cells without hCG pretreatment, which was inhibited by LY294002, but not PD98059. Pretreatment with hCG abolished the IGF1-induced cell proliferation (Fig. 3) .
Recovery of IGF1-induced AKT phosphorylation using siRNA for the suppression of PTEN expression Finally, we explored the effect of inhibition of hCGup-regulated-PTEN. Luteinized granulosa cells transiently transfected with siRNA for PTEN showed the suppression of PTEN expression and a recovery of the phosphorylation of AKT with IGF1 (Fig. 4) . A BrdU cell proliferation assay revealed that hCG-inhibited DNA synthesis in response to IGF1 stimulation was partially recovered in luteinized granulosa cells with knock down of endogenous PTEN (Fig. 5) .
Discussion
In the present study, we demonstrated that PTEN induced to express by hCG in luteinized granulosa cells attenuates AKT phosphorylation and therefore has an anti-proliferative effect. In addition, we recently reported that granulosa cells in large preovulatory follicles expressed higher levels of PTEN than granulosa cells in small follicles showing negligible or occasional staining, suggesting that PTEN expression increases during terminal follicular growth. We also demonstrated that the immunohistochemistry for serial sections showed an inverse relationship between PTEN and phospho-AKT.
IGF1 is undoubtedly significant for folliculogenesis. Female IGF1-null mutant mice fail to ovulate and lack corpora lutea (Baker et al. 1996) . Slot et al. (2006) recently demonstrated that IGF1 treatment results in an increased number of healthy antral follicles with a decreased percentage of atretic follicles in GH receptor knock-out mice, which show a decrease in healthy growing follicles and an increase in atretic follicles compared with wild-type. In bovine granulosa cells, AKT is involved in the cell survival under IGF1 stimulation ). Granulosa cells proliferate and then undergo differentiation, an inverse relationship between the processes being observed during terminal follicular growth (Monniaux & Pisselet 1992) . In this regard, suppressive effects on the IGF1/AKT pathway are speculated to be important to differentiate following proliferation of granulosa cells and maintain steroidogenesis. Our results suggest the possible involvement of PTEN, which increases in expression with LH/hCG stimulation during terminal follicular development, in the regulation of proliferation and differentiation of granulosa cells to maintain a luteinized state.
We also found that two signaling pathways downstream of IGF1, the AKT and ERK pathways, possess different effects and regulatory mechanisms. Ryan et al. (2007) recently reported that both pathways, which are important for dominant follicle selection, show several differences in their expression profile in cattle follicles. However, few reports have investigated differences between the AKT and ERK pathways in expression, effects, and regulation in granulosa cells. We demonstrated that granulosa cell proliferation under IGF1 stimulation are dominantly mediated by the AKT, not ERK, pathway. We also found that ERK, not AKT, is phosphorylated with continuous hCG stimulation. Seto-Young et al. (2003) demonstrated that PD98059 attenuated IGF-induced progesterone production in human granulosa cells. Taken together, the PI3K/AKT pathway downstream of IGF1 might be dominantly involved in granulosa cell proliferation, whereas the ERK pathway downstream IGF1 and hCG may be implicated in steroidogenesis. Granulosa cells adopt a less proliferative and highly steroidogenic form in response to LH during terminal follicular growth and initial luteinization. In support of this point of view, our results show that LH/hCG-induced expression of PTEN affects the PI3K/AKT pathway involved in proliferation, not the MAP kinase/MEK/ERK pathway dominantly involved in steroidogenesis under IGF1 and hCG stimulation (Fig. 6) . However, inhibition of the ERK pathway with PD98059 attenuated FSH-stimulated survival in porcine granulosa cells (Shiota et al. 2003) . The whole picture concerning ERK pathways downstream of factors such as FSH is yet to be fully revealed. Stimulation with LH of matured preovulatory follicles induces the differentiation of granulosa cells into luteinized granulosa cells (Richards et al. 2002) . It has been demonstrated that several molecules that are up-regulated with LH stimulation are involved in granulosa cell differentiation and luteinization. Our findings indicate that PTEN is one such molecule. However, our results showed that DNA synthesis in response to IGF1 stimulation was partially recovered in Figure 3 (A) BrdU proliferation assay. Primary cultured luteinized granulosa cells with (black bars) or without (white bars) pretreatment using 1 IU/ml hCG for 24 h were cultured with 10 ng/ml IGF1, with or without 10 mM LY294002 (LY) or 100 mM PD98059 (PD) for 24 h. The incorporation of BrdU was measured using an ELISA system. BrdU uptake with no treatment was regarded as control. Without hCG-pretreatment, IGF1 induced DNA synthesis in the cells, which was inhibited by LY294002 but not PD98059 (white bars). Pretreatment with hCG attenuated the IGF1-induced DNA synthesis (black bars). Data were analyzed using repeated measures of ANOVA; shown are to represent the meanGS.D. of three independent replicates. Bonferroni correction was used to compare all pairwise. *P!0.05. (B) BrdU proliferation assay comparing fold increase by IGF1 stimulation between cells with (black bars) and without (white bars) pretreatment using 1 IU/ml hCG for 24 h. Data were analyzed using paired t-test; shown are represent the meanGS.D. of three independent replicates. *P!0.05. We used luteinizing granulosa cells in the present study. To estimate the gonadotropin effects more clearly, non-luteinizing granulosa cells obtained at gynecologic surgery would be more appropriate; however, it is very difficult to use abundant human undifferentiated granulosa cells before LH/hCG stimulation for in vitro experiments. KGN (immortalized cells derived from granulosa cell tumor) have sometimes been used instead of primary cultured granulosa cells. KGN might possess steroidogenesis similar to normal granulosa cells; however, it is probable that KGN has different proliferative potential from normal granulosa cells because KGN is a tumor-derived cell line. Granulosa cells obtained from animal ovaries have been used when human undifferentiated granulosa cells were difficult to obtain. Although it is an option, the process and regulation of folliculogenesis may differ in different species, thus, there is a limitation to the use of animal granulosa cells, hence we used luteinizing granulosa cells. Luteinizing is a process that forms a corpus luteum under LH/hCG stimulation; therefore, luteinizing granulosa cells in culture just after oocyte retrieval may possess characteristics of undifferentiated-differentiated transition of granulosa cells. Further studies using undifferentiated granulosa cells, including immortalized human cells, are required to reveal the mechanism and process of luteinization of human granulosa cells under gonadotropin and growth factor stimulation.
Several circumstances have now been identified in which PTEN expression is transcriptionally regulated (Leslie & Downes 2004) . The response of granulosa cells to LH is mediated mainly by cAMP/protein kinase A signaling. LH/hCG has also been shown to stimulate phospholipase C and ERK (Gudermann et al. 1992 , Das et al. 1996 . In the present study, real-time PCR showed that mRNA of PTEN increased with hCG stimulation. Therefore, there is a possibility that these signaling molecules transcriptionally regulate PTEN expression in granulosa cells. The regulatory mechanism of PTEN expression under hormonal stimulation even in other cells has not been well investigated. Guzeloglu-Kayisli et al. (2003) have reported that the PTEN pool is regulated by decreasing phosphorylation with progesterone in human endometrial cells. Phosphorylation of PTEN is implicated in the activation and stabilization of PTEN itself (Gericke et al. 2006) . Further studies are required to reveal how the expression of PTEN is regulated by hormonal stimulation during terminal follicular growth and luteinization as well as its phosphorylation status. Froment et al. (2005) has recently demonstrated that PTEN levels increase during terminal follicular growth in ovine granulosa cells. However, in their experiments, LH did not induce PTEN expression in vitro. The discrepancy with our results regarding the induction of PTEN expression with LH/hCG might be due to the luteinization status of granulosa cells as well as difference of species, regardless of the similar immunohistochemical findings for ovaries.
In conclusion, we demonstrated that PTEN induced to express hCG in luteinized granulosa cells attenuates phosphorylation of AKT, not ERK, and attenuates IGF1-induced cell proliferation. Interestingly, such an increase in PTEN expression has been shown in the proliferation/differentiation transition of human endometrial cells (Mutter et al. 2000) . Therefore, our findings suggest PTEN expression to be one of the triggers for proliferation/differentiation transition in human granulosa cells. Figure 5 BrdU proliferation assay. siRNA-transfected luteinized granulosa cells with or without pretreatment using 1 IU/ml hCG for 24 h were cultured with (black bars) or without (white bars) 10 ng/ml IGF1 for 24 h. The incorporation of BrdU was measured using an ELISA system. Knock down of endogenous PTEN attenuated inhibition of DNA synthesis in response to IGF1 with hCG pretreatment. Data were analyzed using paired t-test; shown are to represent the meanGS.D. of four independent replicates. *P!0.05. Further studies are required to make a detailed evaluation in function and regulation of PTEN in human ovaries.
Materials and Methods
Isolation and culture of luteinized granulosa cells
Human luteinized granulosa cells were collected from follicular fluid obtained via ultrasound-guided transvaginal oocyte retrieval as previously described (Goto et al. 2007) . Briefly, the luteinized granulosa cells after isolation of the oocytes were separated from red blood cells with a Percoll gradient (Amersham Biosciences Corp.) and resuspended in DMEM (Sigma) containing 10% FCS (Sigma), 100 IU/ml penicillin, 100 mg/ml streptomycin, 25 mg/l amphotericin B, and L-glutamine. Then luteinized granulosa cells were seeded onto a 35 mm sterile collagen-coated dish (Biocoat; Becton Dickinson and Co., Franklin Lakes, NJ, USA) or a 4-well chamber slide (Lab-Tek Chamber Slide; Nalge Nunc International, Rochester, NY, USA). This study was approved by the Ethics Committee of Nagoya University Graduate School of Medicine. Informed consent was obtained from patients.
Western blotting for PTEN with hCG stimulation
Primary cultured luteinized granulosa cells were lysed in RIPA buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 5 mM EDTA, 1% sodium deoxycholate, 0.1% SDS, 1.2% aprotinin, 5 mM leupeptine, 4 mM antipain, 1 mM phenylmethylsulfonylfluoride, and 0.1 mM Na 3 VO 4 ) after treatment with various concentrations of hCG for 12, 24 or 48 h. Cell lysates were clarified by centrifugation at 13 000 g for 15 min at 4 8C and diluted in a 2!sample buffer (125 mM Tris-HCl, pH 6.8, 4% SDS, 10% glycerol, 0.2% bromphenolblue, and 4% 2-mercaptoethanol). The protein extract (10 mg) was separated by 10% SDS-PAGE, and transferred to a nitrocellulose membrane. After blocking in PBS containing 5% skim milk for 1 h, the membranes were immunoblotted with anti-human PTEN Ab (A2B1; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA; 1:1000) or anti-b-actin Ab (Santa Cruz Biotechnology, Inc.). Immunoreactive proteins were stained using an ECL system (Amersham Biosciences). Relative band density normalized by b-actin was determined from light scans of the resulting films using densitometric analysis software.
RNA extraction and quantitative RT-PCR
Total RNA was isolated from luteinized granulosa cells in 35 mm dishes using RNeasy Mini Kit (Qiagen Inc.) following the manufacturer's directions. An RT reaction with 1 mg of total RNA was carried out with a first strand cDNA synthesis kit (ReverTra Ace a; Toyobo Co., Ltd, Osaka, Japan). Thereafter, real-time PCR was performed in 96-well 0.2 ml thin-wall PCR plates using the Thermal Cycler Dice (Takara Bio Inc., Tokyo, Japan) and SYBR Premix Ex Taq (Takara Bio Inc.). The real-time PCR mixture contained 1!SYBR Premix Ex Taq, 10 mM PCR primers and 1 mg cDNA in a total volume of 25 ml. The following sets of oligonucleotide primers were used: PTEN, 5 0 -TGACAATCATGTTGCAGCAATTC-3 0 (sense) and 5 0 -CACCAGTTCGTCCCTTTCCA-3 0 (antisense), which correspond to 1376-1398 and 1409-1428 of PTEN cDNA (accession number NM_000314) respectively; GAPDH, 5 0 -CGGGAAACTGTGGCGTGAT-3 0 (sense) and 5 0 -ATGC-CAGTGAGCTTCCCGT-3 0 (antisense), which correspond to 679-696 and 776-794 of GAPDH cDNA respectively. The PCR profile was an initial incubation at 95 8C for 10 s followed by 40 cycles with denaturation at 95 8C for 5 s, and annealing and extension at 60 8C for 30.
Phosphorylation of AKT and ERK1/2 with IGF1
For the detection of phosphorylated AKTand ERK1/2, luteinized granulosa cells with or without hCG-pretreatment were cultured in DMEM without FCS. Then, the cells were stimulated with 100 ng/ml IGF1 (Sigma) for 10 min. The cells were lysed, resolved by 10% SDS-PAGE and transferred as described above. Membranes were immunoblotted with anti-AKT Ab (Santa Cruz Biotechnology, Inc.; 1:500), anti-phospho-AKT Ab (Ser 473; New England BioLabs Inc., Ipswich, MA, USA; 1:1,000), anti-ERK1/2 Ab (C-14; Santa Cruz Biotechnology, Inc.; 1:1000), anti-phospho-ERK1/2 Ab (E-4; Santa Cruz Biotechnology, Inc.; 1:1000), or anti-IGF1R Ab (Ab-5; Lab Vision Corp., Fremont, CA, USA).
BrdU cell proliferation assay
The rate of DNA synthesis was determined from the incorporation of BrdU into cells (BrdU Cell Proliferation Assay; Oncogene Research Products, San Diego, CA, USA) according to the manufacturer's instruction as previously described (Iwase et al. 2006) . Briefly, luteinized granulosa cells were seeded at 1!10 4 on a 96-well microplate, treated using 1 IU/ml hCG for 24 h, and then cultured with or without 100 ng/ml IGF1 for the following 24 h to allow BrdU incorporation. LY294002 (PI3K inhibitor, Promega Corporation), PD98059 (MEK inhibitor, Promega) were added 2 h prior to IGF1. After fixation, the cells were incubated with antiBrdU antibody for 1 h, followed by HRP-conjugated goat antimouse IgG. Then, 100 ml substrate (tetramethylbenzidine) was added to each well after washing and incubated at room temperature for 30 min. The absorbance at dual wave lengths of 450-540 nm was determined using the microplate reader. siRNA siRNA for PTEN was purchased from New England BioLabs (PTEN ShortCut siRNA Mix). Luteinized granulosa cells pretreated with hCG for 24 h were transfected by siRNA for PTEN or negative control siRNA AF 488 at a final concentration of 10 nM using HiPerfect Transfection Reagent (Qiagen) according to the manufacturer's instructions. The cells were lysed 48 h post-transfection, resolved by 10% SDS-PAGE, transferred, and immunoblotted as described above. The 24 hpost-transfected cells were cultured with or without 100 ng/ml IGF1 for the next 24 h for a BrdU cell proliferation assay as described above.
